CF®647 Dye used for imaging of beta-cell targeted PD-1 agonist in a live human pancreas slice model of type I diabetes
Targeted activation of immune checkpoints is an emerging strategy for treating Type 1 Diabetes (T1D), where autoreactive T cells destroy insulin-producing beta



